SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-059457
Filing Date
2018-09-28
Accepted
2018-09-28 17:04:48
Documents
3
Period of Report
2018-09-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-36079_18k.htm 8-K 49109
2 EX-4.1 a18-36079_1ex4d1.htm EX-4.1 616201
3 EX-4.2 a18-36079_1ex4d2.htm EX-4.2 457280
  Complete submission text file 0001104659-18-059457.txt   1124118
Mailing Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500 8479376100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 181094847
SIC: 2834 Pharmaceutical Preparations